The growth of Viagra and its effect on the medicinal landscape presents a complicated question for shareholders. While the initial sales figures were impressive, the patent has lapsed, leading to a flood of off-brand https://henripzpa150154.activablog.com/40381717/the-blue-pill-and-the-pharmaceutical-industry-a-speculative-bet